CYP2J2 polyclonal, anti-human, primate
€470.00
In stock
SKU
AC-AP69404
Catalog Number: AC-AP51347
Size: 100 µl
Host: Rabbit
Applications: WB, ICC, IHC-P, E
Datasheet
Request Information
Size: 100 µl
Host: Rabbit
Applications: WB, ICC, IHC-P, E
Datasheet
Request Information
Background:
Metabolizes arachidonic acid predominantly via a NADPH- dependent olefin epoxidation to all four regioisomeric cis- epoxyeicosatrienoic acids. One of the predominant enzymes responsible for the epoxidation of endogenous cardiac arachidonic acid pools (PubMed:8631948). Catalyzes the monooxygenation of a various compounds, such as danazol, amiodarone, terfenadine, astemizole, thioridazine, tamoxifen, cyclosporin A and nabumetone (PubMed:19923256). Catalyzes hydroxylation of the anthelmintics albendazole and fenbendazole (PubMed:23959307). Catalyzes the sulfoxidation of fenbedazole (PubMed:19923256).
Other Names:
CYP2J2; Cytochrome P450 2J2; Arachidonic acid epoxygenase; CYPIIJ2
Antigen Type: synthetic peptide
Antigen Type: CYP2J2 {ECO:0000303|PubMed:19737933, ECO:0000312|HGNC:HGNC:2634}
Gene ID: 1573
Primary Accession: P51589
Metabolizes arachidonic acid predominantly via a NADPH- dependent olefin epoxidation to all four regioisomeric cis- epoxyeicosatrienoic acids. One of the predominant enzymes responsible for the epoxidation of endogenous cardiac arachidonic acid pools (PubMed:8631948). Catalyzes the monooxygenation of a various compounds, such as danazol, amiodarone, terfenadine, astemizole, thioridazine, tamoxifen, cyclosporin A and nabumetone (PubMed:19923256). Catalyzes hydroxylation of the anthelmintics albendazole and fenbendazole (PubMed:23959307). Catalyzes the sulfoxidation of fenbedazole (PubMed:19923256).
Other Names:
CYP2J2; Cytochrome P450 2J2; Arachidonic acid epoxygenase; CYPIIJ2
Antigen Type: synthetic peptide
Antigen Type: CYP2J2 {ECO:0000303|PubMed:19737933, ECO:0000312|HGNC:HGNC:2634}
Gene ID: 1573
Primary Accession: P51589
| Is Featured? | No |
|---|
Write Your Own Review